Hydromorphone Hydrochloride Injection
Injection
Current Active — Day 3114
High impact — Only one manufacturer supplies this drug; any disruption leaves no immediate alternative source.
FDA shortage record
- Substance
- Hydromorphone Hydrochloride Injection
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Dosage form
- Injection
- Presentation
- Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)
- Therapeutic category
- Analgesia/Addiction
- Package NDC
0641-0121-25- Initially posted
- 11/03/2017
- Days on shortage list
- 3114
- Current FDA status
- Current
- Shortage entries (current dataset)
- 1 record for Hydromorphone Hydrochloride Injection
Reason and context
Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 800-631-2174.
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.